Literature DB >> 1812634

BCG vaccine in urinary bladder cancer.

S A Brosman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1812634      PMCID： PMC1003114     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  4 in total

1.  Intravesical bacillus Calmette-Guérin administration in the prophylaxis of superficial bladder cancer.

Authors:  M D Melekos; A Pantazakos; S Markou; C Skopa; A Athanassopoulos; G Barbalias
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

Review 2.  Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview.

Authors:  J A Witjes; A P vd Meijden; F M Debruyne
Journal:  Urol Int       Date:  1990       Impact factor: 2.089

Review 3.  Mechanisms of action of intravesical bacillus Calmette-Guerin for bladder cancer.

Authors:  D J Mikkelsen; T L Ratliff
Journal:  Cancer Treat Res       Date:  1989

4.  Intravesical bacillus Calmette-Guerin for patients with high-risk superficial bladder cancer.

Authors:  I W Klimberg; J M Pow-Sang; C K Cartwright; Z Wajsman
Journal:  Urology       Date:  1991-02       Impact factor: 2.649
  4 in total
  1 in total

Review 1.  Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates.

Authors:  Joseph J Barchi
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.